Abstract B131: Association between type 2 diabetes and prevalence of monoclonal gammopathy of undetermined significance in a large screened U.S. populationEtienne X. Holder, Kimberly A. Bertrand, Mallory Bernstein et al.|Cancer Epidemiology Biomarkers & Prevention|2025Cited by 0
Association between soluble immune biomarkers and monoclonal gammopathy of undetermined significance (MGUS) in three large cancer epidemiology cohorts with participants from underrepresented groups.Mallory Bernstein, Wendy Cozen, Jia Y. Wan et al.|Blood|2025Cited by 0
Laboratory characteristics of monoclonal gammopathy of undetermined significance (MGUS) in a diverse sample from three large cancer epidemiology cohorts.Jane A. Emerson, Wendy Cozen, Sabrina Brzostek et al.|Blood|2025Cited by 0
A nested case-control study of monoclonal gammopathy of undetermined significance in the Multiethnic Cohort studyMaryam Salehi, Wendy Cozen, Mallory Bernstein et al.|Blood Advances|2026Cited by 0